Responses to immune checkpoint inhibitors in nonagenarians

DOI: 10.1080/2162402X.2016.1234572

Keywords: Advanced melanoma, elderly, immunotherapy, ipilimumab, nivolumab, pembrolizumab

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text